WO2001068919A2 - Mutation detection using denaturing gradients - Google Patents
Mutation detection using denaturing gradients Download PDFInfo
- Publication number
- WO2001068919A2 WO2001068919A2 PCT/US2001/007906 US0107906W WO0168919A2 WO 2001068919 A2 WO2001068919 A2 WO 2001068919A2 US 0107906 W US0107906 W US 0107906W WO 0168919 A2 WO0168919 A2 WO 0168919A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polynucleotide
- target
- wild type
- probe
- mutant
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
Definitions
- the present invention relates generally to the field of genetic analysis, particularly to the detection of single nucleotide polymorphisms.
- the human genome is made up of approximately 30,000 unique genes, which control the development and characteristics of the mature human. Each gene is composed of a sequence of nucleotides which are generally conserved across the species and are referred to as wild type.
- Single nucleotide polymorphisms SNPs are nucleotide sequence variants from the predominant wild type. Typically, single nucleotide polymorphisms are associated with expressed mutations. There is considerable interest in the development of methods which permit the rapid, accurate identification of single nucleotide polymorphisms.
- Nerenberg, Canter and Radtkey in WO/061805 (Nanogen/Becton Dickinson Partnership, 10/19/00) describe methods for the analysis of SNPs using an electronically bioactive microchip.
- the present invention provides methods for detecting single nucleotide polymorphisms in a sample by applying an energy gradient to a mixture of probe- hybridized target wild type and mutant polynucleotides.
- a nucleotide probe having a nucleotide sequence complementary to at least a portion of one strand of either the target wild type or target mutant polynucleotide(s), is exposed to a sample containing target wild type polynucleotide(s) and target mutant polynucleotide(s) under hybridizing conditions. If a wild type probe is used, target wild type polynucleotide(s) will form homoduplexes with the wild type probe, while target mutant polynucleotide(s) will form heteroduplexes with the wild type probe.
- target mutant polynucleotide(s) will form homoduplexes with the mutant probe, while target wild type polynucleotide(s) will form heteroduplexes with the mutant probe.
- Either the probe or the target may be attached to a suitable solid support.
- An energy gradient is applied to the duplex-containing sample to induce selective denaturation of the duplexes.
- the gradient may be a thermal or chemical one and is preferably temporally linear.
- the hetero- and homo-duplexes deanneal at different times so that the detection of more than one type of polynucleotide(s) is indicative of a single nucleotide polymorphism.
- a reference homozygous wild type is used as a control. In those cases in which both alleles of a test sample are mutant, only a single eluent peak or signal will be detected. The presence of mutation may be confirmed by comparing the elution time to that of the control.
- Capillary electropheresis, gel electropheresis, high performance liquid chromatography, or microfluidics are typically used for identification of the separated strands.
- Fig. 1 A depicts silica bead (11) and immobilized probe (12) in an HPLC column or other suitable reaction cartridge (15) with target mutant nucleic acid (13) and target wild type nucleic acid (14) being loaded onto cartridge (15) with the flow of eluent (16).
- Fig. IB depicts immobilized probe (12), target mutant nucleic acid (13) and target wild type nucleic acid (14) subjected to hybridization conditions, representing the hybridization product of target mutant nucleic acid (13) and probe (12) as a heteroduplex and the hybridization product of target wild type nucleic acid (14) and probe (12) as a homoduplex, both suspended in eluent (16) contained within an HPLC column or other suitable reaction cartridge (15).
- Fig. 1C illustrates the denaturation of the heteroduplex hybridization product, whereby probe (12) is separated from target mutant nucleic acid (13) under deannealing conditions.
- Deannealing conditions are imposed by suitable means such as controlling temperature, the concentration of chemical denaturants (e.g., urea, formamide, NaOH etc), ionic strength, and/or the pH of eluent(16) in HPLC column(15).
- Fig. ID shows deannealed target mutant nucleic acid (13) migrating into the flow path of eluent (16).
- the Figure also represents intact homoduplex (14) contained within HPLC column (15) along with free bead (11) and immobilized probe (12).
- Fig. IE depicts the intact homoduplex hybridization product of target wild type nucleic acid (14), probe (12) and bead (11) contained within cartridge (15).
- Fig. IF illustrates the homoduplex hybridization product, silica bead (11), immobilized probe (12) and target wild type nucleic acid (14) undergoing deannealing conditions. Deannealing conditions are imposed by suitable means such as controlling temperature, the concentration of chemical denaturants (e.g., urea, formamide, NaOH etc), ionic strength, and/or the pH of eluent (16) in HPLC column (15).
- suitable means such as controlling temperature, the concentration of chemical denaturants (e.g., urea, formamide, NaOH etc), ionic strength, and/or the pH of eluent (16) in HPLC column (15).
- Fig. 1G represents deannealed homoduplex.
- the target wild type nucleic acid (14) has deannealed from immobilized probe (12) and left HPLC column (15), migrating into the flow path of eluent (16). Free silica beads (11) and immobilized probes (12) remain in the HPLC column (15).
- Fig. 2A depicts hybridization products comprising target mutant nucleic acids (23) and target wild type nucleic acids (24) bound to probes (22) on beads (21).
- Beads (21) will have at least one probe (22) and preferably a plurality of probes (22).
- the hybridization product of target mutant nucleic acid (23) and probe (22) is heteroduplex and the hybridization product of target wild type nucleic acid (24) and probe (22) is homoduplex. These products are suspended in buffer (26) contained within a well (25) of an electrophoresis gel.
- Fig. 2B illustrates the heteroduplex hybridization product of silica beads (21) and target mutant nucleic acid (23) undergoing deannealing conditions.
- Deannealing conditions are imposed by suitable means such as controlling temperature, the concentration of chemical denaturants (e.g., urea, formamide, NaOH etc), ionic strength, and/or the pH of running buffer (26) contained in well (25).
- suitable means such as controlling temperature, the concentration of chemical denaturants (e.g., urea, formamide, NaOH etc), ionic strength, and/or the pH of running buffer (26) contained in well (25).
- Fig. 2C represents target mutant nucleic acid (23) deannealed from immobilized probe (22) leaving the well (25) and migrating into the gel (27) matrix due to the applied voltage across the gel (27).
- the Figure also shows intact homoduplex contained within the well (25) along with free silica bead (21) and immobilized probe (22).
- Fig. 2D depicts the intact homoduplex hybridization product of target wild type nucleic acid (24) with probe (22) on silica bead (21), free silica bead (21) and immobilized probe (22).
- Fig. 2E illustrates the homoduplex hybridization product, with target wild type nucleic acid (24) undergoing deannealing conditions.
- Deannealing conditions are imposed by suitable means such as controlling temperature, , the concentration of chemical denaturants (e.g., urea, formamide, NaOH etc), ionic strength, and/or the pH of running buffer (26) contained in well (25).
- suitable means such as controlling temperature, , the concentration of chemical denaturants (e.g., urea, formamide, NaOH etc), ionic strength, and/or the pH of running buffer (26) contained in well (25).
- Fig. 2F represents target wild type nucleic acid (24) deannealed from immobilized probe (22) leaving the well (25) and migrating into the gel (27) matrix, due to the applied voltage across the gel (27).
- the Figure also represents free silica bead (21) with immobilized probe (22) remaining in the well (25).
- Fig. 3 depicts target mutant nucleic acid (32) separating in an electrophoresis gel (33) from target wild type nucleic acid (31).
- Fig. 4A represents an HPLC profile of the target mutant nucleic acid (42) and target wild type nucleic acid (41), showing 2 distinct peaks. Temperature gradient TI — • T2 is shown at the top of the Figure.
- Fig. 4B illustrates an HPLC profile of target wild type nucleic acid (41) showing only one peak, along with the temperature gradient.
- Fig. 5 A depicts microwell (51) having immobilized probes (52) and media (53).
- Fig. 5B depicts denatured target wild type nucleic acid (54) and target mutant nucleic acid (55) added to the microwell (51) for hybridization with probes (52) in media (53).
- Fig 5C shows microwell (51), representing the heteroduplex hybridization product (57) of target mutant nucleic acid (55) and probe (52) and the homoduplex hybridization product (56) of target wild type nucleic acid (54) and probe (52), suspended in buffer (53).
- Fig. 5D depicts the microwell of Fig. 5C with an electrophoresis capillary inserted into well (51).
- the arrow indicates the direction of electrophoretic mobility.
- Figs. 5E & 5F illustrate the heteroduplex hybridization product (57) undergoing deannealing conditions. Deannealing conditions are imposed by suitable means such as controlling temperature, the concentration of chemical denaturants (e.g., urea, formamide, NaOH etc), ionic strength, and/or the pH of buffer ( 16) in microwell (51).
- the target mutant nucleic acid (55) has deannealed from immobilized probe (52) and left microwell (51) and migrated into the electropheresis capillary (58).
- the arrow indicates the direction of electrophoretic mobility of target mutant nucleic acid (55).
- the homoduplex (56) is still intact and contained within microwell (51).
- Figs. 5G & 5H illustrate the homoduplex hybridization product (56) undergoing deannealing conditions.
- Deannealing conditions are imposed by suitable means such as controlling temperature, the concentration of chemical denaturants (e.g., urea, formamide, NaOH etc), ionic strength, and/or the pH of buffer (53) microwell (51).
- the target wild type nucleic acid (54) has deannealed from immobilized probe (52) and left microwell (51) and migrated into the electropheresis capillary (58) due to the applied voltage across the capillary (58).
- the arrow indicates the direction of electrophoretic mobility of target wild type nucleic acid (54).
- Immobilized probe (52) remains in microwell (51).
- Fig. 51 & J represent electropherograms of the target mutant nucleic acid (55) and target wild type nucleic acid (54). When a single strand mutation is present, electropheresis will show two distinct peaks (59 for wild type & 60 for mutant).
- the chart K represents the temperature gradient imposed upon the microwell (51).
- heteroduplex refers to the hybridization product of a wild type oligonucleotide probe with the sense or antisense strand of a target gene or polynucleotide having at least one nucleotide variant from the predominant wild type gene or polynucleotide.
- the heteroduplex may be the hybridization product of a mutant oligonucleotide probe with the sense or antisense strand of a target wild type gene or polynucleotide
- homoduplex refers to the hybridization product of a wild type oligonucleotide probe with the sense or antisense strand of a target wild type gene or polynucleotide.
- the homoduplex may also be the hybridization product of a mutant probe with a mutant target.
- linear thermal denaturant gradient means a constant rate of increase in temperature per unit time over the entire period during which the temperature is increased (first order kinetics).
- TI is defined as the starting temperature of the temperature gradient and may be either ambient (room) temperature or any temperature lower than the lowest Tm (deannealing T) of any heteroduplex present in the sample being analyzed.
- T2 is defined as the final temperature of the temperature gradient and is any temperature greater than the highest Tm of any homoduplex present in the sample being analyzed. T2 will generally be 5-10°C above the highest homoduplex Tm present in the sample being analyzed.
- the time of the gradient is determined by several factors, such as format employed (e.g., CE, PAGE or HPLC), desired resolution, number of different loci being screened, et al.
- linear chemical denaturant gradient means a constant rate of increase over time in the concentration of chemical reagents, such as urea, formamide, NaOH, etc. which disrupt hydrogen bonding between double-stranded nucleic acid duplexes.
- Dl is defined as the starting denaturant concentration and "D2" is defined as the final denaturant concentration.
- Dl may range from a complete absence of denaturant to any concentration sufficiently low to be ineffective in deannealing of any heteroduplex present in the sample being analyzed.
- D2 is any denaturant concentration sufficient to cause complete disruption of hydrogen bonding and deannealing of any homoduplex with the highest Tm present in the sample being analyzed.
- single nucleotide polymorphism is used herein to describe any nucleotide sequence variant from the predominant wild type. Typically, single nucleotide polymorphisms are associated with expressed mutations.
- wild type refers to a nucleotide sequence associated with the predominant naturally occurring gene.
- This invention relates to novel diagnostic or mutation-screening-methods which allows several loci, derived from multiple DNA samples, to be rapidly and simultaneously screened for mutations in discrete areas of specific genes.
- This invention describes the implementation of this mutation screening method in four different formats: capillary electrophoresis (CE); polyacrylamide gel electrophoresis (PAGE); high performance liquid chromatography (HPLC), and microfluidics.
- the samples consist of either labeled or unlabeled, single-or double-stranded DNA fragments or "targets" (of various lengths) which have been hydrogen-bonded (annealed) to "probes” consisting of either oligonucleotides (typically 20-40 nucleotides in length) or melting temperature domain-length (typically 50-300 nt) single-stranded DNA fragments immobilized on microscopic and/or macroscopic particles or other substrates of various diameters and chemical compositions.
- the targets may be immobilized on a solid support.
- heteroduplexes containing sites of base mismatch between the probe and target which will substantially lower the melting temperature (Tm) of the heteroduplex compared to the corresponding homoduplex.
- Tm melting temperature
- the heteroduplexes will be the first to dissociate (deanneal), followed by homoduplex dissociation at a higher temperature or higher denaturant concentration.
- hetero- and homoduplex pair being subjected to the linear temporal temperature or chemical denaturant increase are placed into either an electrical field (CE and PAGE) or the flow of solvent (HPLC), their different times of deannealing and hence, mobilization from the solid supports will allow them to be distinguished from one another as either two different bands in PAGE or as two different peaks in CE and HPLC respectively.
- CE and PAGE electrical field
- HPLC flow of solvent
- This invention provides a method for the detection of mutations based upon the different chemical and thermal stabilities of homo- and heteroduplex DNA or cDNA fragments.
- the inventive process relies upon the recognition that the homo- and heteroduplex complexes are responsive to different denaturing conditions.
- the imposition of either a linear thermal denaturant gradient (in e.g., CE, PAGE and HPLC formats) or a linear chemical denaturant gradient (in e.g., HPLC and other formats) upon a probe-target duplex results in differential separation of the homo- and heteroduplexes.
- the probe or target are optionally attached to a solid support, such as a bead or other solid support, as is known in the art.
- the solid support is a silica or polymeric bead or other material capable of being derivatized.
- the form of the support may be participate (macroscopic and/or microscopic), filters, membranes, fibers, sheets, solid surfaces (e.g., inner walls of tubes and microwells) and the like. Immobilization may be achieved by means well known in the art, such as by formation of an amide bond, by avidin/streptavidin or biotin/streptavidin attachment, or by synthesis of the probe or PCR primer directly on the solid support.
- the probe or target incorporates a detection label.
- Preferred labels include: radioisotopes, chemiluminescent, luminescent and fluorescent agents (fluor), cofactors and the like.
- This invention encompasses methods and apparati for performing nucleic acid hybridization on a solid support.
- the practice of the present invention employs conventional techniques of chemistry, molecular biology, microbiology, and recombinant DNA technology well known to the skilled artisan.
- Hybridization reactions are preferably performed at a separate work station by adjusting one or more factors influencing hybridization, including temperature, and/or ionic strength and pH.
- a region of a specific wild type gene (or of several different genes) known to be a site of mutational incidence i.e., a "hot spot"
- a probe is synthesized which is fully complementary to this area of the sense strand of the wild type sequence.
- oligonucleotide probes will suffice.
- the probe is designed to encompass the putative site of mutation by placing it either in the middle of the oligonucleotide sequence or well within the interior of the probe.
- a probe is synthesized to include an amino (NH 2 ) group on either the 5'- or 3' -end to allow covalent attachment of the probe to a carboxylated solid support.
- the terminally aminated probes are incubated with the carboxylated particles with the appropriate reagents in order to achieve coupling.
- the derivatized particles are then collected by either centrifugation or filtration.
- the probes will consist of much longer single-stranded DNA fragments which are designed to be complementary to melting temperature domains within the gene or locus being screened.
- the length and composition of these domain-length probes are determined by thermodynamically modeling the sample wild type gene or locus using a program such as MELT.
- a wild type sequence is selected for use as a PCR template.
- the PCR primer that is incorporated into the sense strand contains a 5'-amino group.
- the sense strand is covalently attached to a solid support and the antisense strand is removed by denaturation and washing.
- PCR or plasmid cloning
- the amplification process can be either linear (single primer) or exponential (two primers), depending upon individual requirements.
- the PCR primers are designed such that the primer that will be incorporated into the sense strand of the target will contain a fluor on its 5'-end.
- other types of labeling such as radiolabeling or chemiluminescent labeling may also be employed. The presence of a fluor or other label will enhance the sensitivity of detection. Fluors can be excited with ultraviolet illumination, high wattage xenon or krypton lamps or lasers.
- the target may be visualized by staining the gel with agents such as ethidium bromide, SYBR Green or silver staining.
- agents such as ethidium bromide, SYBR Green or silver staining.
- HPLC high-density polyethylene glycol
- a sufficient mass amount of target will allow detection via absorption.
- Capillary electrophoresis relies upon a fluorescently labeled target and excitation with a laser.
- This format is intended to employ either single or multiple capillary instruments, including capillary based automated sequencers.
- a target fragment is amplified via PCR and a primer with a 5 '-fluor is incorporated into the sense strand. If the locus is heterozygous due to mutation, both wild type and mutant allelic target fragments will be synthesized.
- the labeled target(s) may be washed to remove unincorporated PCR primer and transferred to a tube/micro well containing one or more complementary probes immobilized on a solid support. The sample is thermally cycled to induce hybridization between the labeled target(s) and the immobilized probe(s).
- Mutant allelic target strands will form heteroduplexes with the probe(s), while wild type allelic target fragments will form homoduplexes.
- free (unannealed) target fragments may be removed by centrifugation, ultrafiltration or other methods prior to analysis.
- the capillary may simply be prerun and unincorporated target removed electrophoretically prior to the actual analysis.
- the sample tube/microwell is placed within an appropriate heating device and the sample pre- equilibrated to room or other appropriate temperature (TI). As analysis begins, a linear temporal temperature gradient is initiated around the tube, gradually raising the temperature of the contents while the flow of current is initiated through the capillary.
- the Tm of the heteroduplex will be reached first, resulting in deannealing and electrophoretic mobilization of the labeled mutant target strand into the capillary.
- the temperature is increased linearly over an appropriate period of time until a point (T2) approximately 5-10°C above the calculated Tm of the homoduplex.
- T2 a point approximately 5-10°C above the calculated Tm of the homoduplex.
- the wild type target strand deanneals and is mobilized into the capillary. Due to the different times of mobilization, the mutant and wild type target strands are now spatially separated within the capillary and can be distinguished as two independent signals.
- the fluorescent tags on the target strands are excited and a signal emitted. UN absorption may also be used for detection.
- the presence of a single signal or peak may indicate a homozygous or wild type sample (i.e. no mutation), while two (or more) signals or peaks per sample indicates the presence of a mutation.
- a single peak may also be indicative of a mutation if both alleles are mutant. The mutant will however elute at a different time when compared to a reference homozygous wild type control.
- the PCR-amplified target samples are transferred to a 96- or 384-well (or greater) PCR, ELISA or microwell plate in which the walls and/or well bottom have been modified with bound probe.
- each well may contain immobilized probe bound to a particulate or other substrate.
- the plate is placed into a heating device (e.g., thermal cycler) which will allow a linear temporal temperature gradient to be uniformly applied to each well.
- a heating device e.g., thermal cycler
- each well of the plate may contain more than one species of bound probe, corresponding to either more than one area of one particular gene or to defined areas of several genes. For example, if the polymorphic region of a single gene is 80 base pairs in length, it may be subdivided into four oligonucleotide probes, each 20 nucleotides in length.
- the Tms of the different oligonucleotides used in the multiplex format can be manipulated by changing the lengths to prevent comigration of different labeled fragments.
- Four sets of PCRs are carried out, each of which will incorporate a different fluorescent tag onto the 5 '-end of a sense target strand.
- each fluor represents a different 20-base pair region of the polymorphic area.
- the presence of single or double signal peaks for each fluor indicates the presence (double peak) or absence (single peak) of a mutation within the respective 20-base pair area.
- regions from several different genes may be screened simultaneously by using multiple fluors.
- sites of likely mutation from four different genes could be screened by carrying out a separate PCR for each of the four different loci, with each reaction incorporating a different fluor onto the 5 '-end of the sense target strand.
- the respective well of the plate contains four different wild type species of probe, each complementary to one labeled complementary target strand.
- the heteroduplexes will dissociate first, followed by the homoduplex counterpart. In this manner, each fluor will generate either a single peak if both allelic forms of the locus are wild type or two peaks, if one member of the allelic pair is mutated.
- Tm heteroduplex
- T2 must be several degrees higher than the highest homoduplex Tm present.
- Tl ambient can routinely be used for these analyses.
- the Tms of all homoduplexes intended for simultaneous analyses are calculated in order to determine the appropriate linear temporal temperature range to be applied. If necessary, loading buffers containing denaturants such as urea and/or formamide may be employed to lower the temperatures required for analysis.
- PAGE Polyacrylamide gel
- An aliquot of the amplified fragment(s) is (are) combined with an aliquot of the wild type probe-derivatized particles/substrate in an appropriate aqueous buffer and first heated, then cooled in order to achieve hybridization between the labeled sense strand of the PCR product(s) and the complementary immobilized probe.
- Target PCR strands of wild type sequence will form homoduplexes with the probes, while mutant target strands will form heteroduplexes.
- the annealed target/probe duplex is then diluted into an appropriate loading buffer and loaded into a well of the gel. Once again, the loading buffer can be supplemented with urea, formamide or other denaturant to lower the temperatures required for analysis.
- PAGE analyses are carried out in an acrylamide gel placed within a vertical (or horizontal) electrophoresis apparatus which has been modified to include an element or module programmed to introduce a linear temporal temperature gradient to either the upper area of the gel (wells) in which the samples have been loaded or evenly across the entire area of the gel.
- a heating module is attached to the front of the gel/plate assembly. This particular apparatus is included in this embodiment of the invention.
- the hydrogen-bonded PCR fragments will not exhibit any mobility because they are firmly immobilized onto the particles which are too large to migrate into the polyacrylamide gel matrix.
- the presence of a single signal or peak may indicate a homozygous or wild type sample (i.e. no mutation), while two (or more) signals or peaks per sample indicates the presence of a mutation.
- a single peak may also be indicative of a mutation if both alleles are mutant. The mutant will however elute at a different time when compared to a reference homozygous wild type control.
- the acrylamide gel is illuminated with the appropriate lamp and the number of DNA fragments per lane determined. Where mass amounts permit, the gel may be stained with either ethidium bromide, SYBR Green or other appropriate stain (e.g., silver) and the DNA fragments visualized by illumination with ultraviolet light. Temperature stable agarose formulations and agarose/acrylamide mixtures may also be used.
- Electrophoretic analysis may also be carried out using an automated DNA sequencer (e.g., ABI 377) which has been fitted with a module to introduce a linear temporal temperature gradient to the well area of the gel and/or to the entire gel.
- the target fragments are labeled with an appropriate fluor and data acquisition occurs in real-time, obviating the requirement for gel staining and scanning.
- This format also allows the use of several different fluors per lane, providing an opportunity for multiplex analysis and increased throughput.
- High Performance Liquid Chromatography (HPLC) format HPLC analyses employ an HPLC column or reaction cartridge packed with particles or other substrates to which wild type gene-specific probes have been covalently attached.
- HPLC analysis may be carried out using either a linear temporal temperature gradient or a linear temporal chemical denaturant gradient.
- a linear temporal temperature gradient the column is housed in an oven or encased in a heating/cooling device (e.g., Peltier) which is in-line with the HPLC instrument and allows the temperature of the column to be controlled.
- a heating/cooling device e.g., Peltier
- the sample containing target DNA is heated for an appropriate time to facilitate deannealing of the complementary target strands.
- the denatured sample (target) is then injected into the instrument port and annealed to the immobilized probes at an appropriate temperature.
- hybridization of the target to the probe may occur in a column/reaction cartridge that is placed into an appropriate heating/cooling device external to the HPLC instrument and the column fitted into the HPLC instrument after hybridization.
- the flow of solvent through the column is then initiated as the column temperature is simultaneously increased along a linear temporal temperature gradient from TI to T2.
- the column may be maintained at a constant temperature and a linear gradient of chemical denaturant(s) introduced over an appropriate period of time. Under a constant flow of solution in the presence of either a linear temperature gradient or a linear chemical denaturant gradient, the heteroduplex will be the first to deanneal and the mutant DNA target fragment mobilized.
- the homoduplex will deanneal, resulting in mobilization of the wild type DNA target fragment.
- the mobilized fragment(s) can be detected by a variety of methods.
- the presence of a single signal or peak may indicate a homozygous or wild type sample (i.e. no mutation), while two (or more) signals or peaks per sample indicates the presence of a mutation.
- a single peak may also be indicative of a mutation if both alleles are mutant. The mutant will however elute at a different time when compared to a reference homozygous wild type control.
- an upstream combination thermal cycler/autosampler may be used. PCR amplification and sample denaturation occur within this module, allowing multiple subject samples to be amplified and screened unattended. Microfluidics format
- the probe or target is be localized within a region of a microfluidic device, incorporating single or mutiple channels on a solid substrate.
- a microfluidic device incorporating single or mutiple channels on a solid substrate.
- Such devices are disclosed, for example, in U.S. Patent Nos. 6,153,013; 6,180,536; and 6,186,660.
- Complementary probe or target is introduced and hybridization induced.
- hybridization may be carried out at a separate work station, independent of the microfluidic device. Either a chemical or thermal gradient is imposed and the separated deannealed products are detected. This format is conducive to rapid, high throughput analyses.
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001245650A AU2001245650A1 (en) | 2000-03-10 | 2001-03-12 | Mutation detection using denaturing gradients |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18853400P | 2000-03-10 | 2000-03-10 | |
US60/188,534 | 2000-03-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001068919A2 true WO2001068919A2 (en) | 2001-09-20 |
WO2001068919A3 WO2001068919A3 (en) | 2002-12-05 |
Family
ID=22693562
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/007906 WO2001068919A2 (en) | 2000-03-10 | 2001-03-12 | Mutation detection using denaturing gradients |
Country Status (3)
Country | Link |
---|---|
US (2) | US6596487B2 (en) |
AU (1) | AU2001245650A1 (en) |
WO (1) | WO2001068919A2 (en) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002061410A1 (en) * | 2000-09-01 | 2002-08-08 | Spectrumedix Corporation | System and method for temperature gradient capillary electrophoresis |
CA2425413A1 (en) * | 2000-10-11 | 2002-04-18 | Spectrumedix Corporation | System and method for determining the presence of methylated cytosines in polynucleotides |
US6486309B1 (en) * | 2001-08-01 | 2002-11-26 | Varian, Inc. | Method of detecting sequence variations in macromolecules by thermal gradiant |
DE10149947A1 (en) * | 2001-10-10 | 2003-04-17 | Febit Ferrarius Biotech Gmbh | Isolating target molecules, useful for separating e.g. nucleic acids for therapy or diagnosis, comprises passing the molecules through a microfluidics system that carries specific receptors |
WO2003033743A1 (en) * | 2001-10-18 | 2003-04-24 | Spectrumedix Corporation | System and method for temperature gradient capillary electrophoresis |
US7413859B2 (en) * | 2001-11-14 | 2008-08-19 | Siemens Aktiengesellschaft | Method and biosensors for detecting macromolecular biopolymers |
EP1359228B1 (en) * | 2002-04-23 | 2013-11-27 | Accenture Global Services Limited | DNA authentification based on scattered-light detection |
AU2003256579A1 (en) * | 2002-07-16 | 2004-02-02 | Spectrumedix Llc | Method and system for comparative genomics for organisms using temperature gradient electrophoresis |
GB0224986D0 (en) | 2002-10-28 | 2002-12-04 | Smith & Nephew | Apparatus |
US7300755B1 (en) * | 2003-05-12 | 2007-11-27 | Fred Hutchinson Cancer Research Center | Methods for haplotyping genomic DNA |
US7303879B2 (en) * | 2003-07-31 | 2007-12-04 | Applera Corporation | Determination of SNP allelic frequencies using temperature gradient electrophoresis |
US7279280B2 (en) * | 2003-09-25 | 2007-10-09 | Mgp Biotech, Inc. | Apparatus and method for detecting genetic mutations and single nucleotide polymorphisms |
GB0325129D0 (en) | 2003-10-28 | 2003-12-03 | Smith & Nephew | Apparatus in situ |
US11298453B2 (en) | 2003-10-28 | 2022-04-12 | Smith & Nephew Plc | Apparatus and method for wound cleansing with actives |
US7776028B2 (en) | 2004-04-05 | 2010-08-17 | Bluesky Medical Group Incorporated | Adjustable overlay reduced pressure wound treatment system |
US10058642B2 (en) | 2004-04-05 | 2018-08-28 | Bluesky Medical Group Incorporated | Reduced pressure treatment system |
US7708724B2 (en) * | 2004-04-05 | 2010-05-04 | Blue Sky Medical Group Incorporated | Reduced pressure wound cupping treatment system |
US8062272B2 (en) | 2004-05-21 | 2011-11-22 | Bluesky Medical Group Incorporated | Flexible reduced pressure treatment appliance |
US7909805B2 (en) | 2004-04-05 | 2011-03-22 | Bluesky Medical Group Incorporated | Flexible reduced pressure treatment appliance |
US10413644B2 (en) | 2004-04-27 | 2019-09-17 | Smith & Nephew Plc | Wound treatment apparatus and method |
US8529548B2 (en) | 2004-04-27 | 2013-09-10 | Smith & Nephew Plc | Wound treatment apparatus and method |
US7753894B2 (en) | 2004-04-27 | 2010-07-13 | Smith & Nephew Plc | Wound cleansing apparatus with stress |
GB0409446D0 (en) | 2004-04-28 | 2004-06-02 | Smith & Nephew | Apparatus |
US20060008823A1 (en) * | 2004-05-12 | 2006-01-12 | Kemp Jennifer T | DNA profiling and SNP detection utilizing microarrays |
US7569742B2 (en) | 2005-09-07 | 2009-08-04 | Tyco Healthcare Group Lp | Self contained wound dressing with micropump |
EP2021503A1 (en) * | 2006-03-17 | 2009-02-11 | Solexa Ltd. | Isothermal methods for creating clonal single molecule arrays |
US7779625B2 (en) | 2006-05-11 | 2010-08-24 | Kalypto Medical, Inc. | Device and method for wound therapy |
DK3000448T3 (en) | 2007-11-21 | 2019-01-21 | Smith & Nephew | Wound dressing |
GB0722820D0 (en) | 2007-11-21 | 2008-01-02 | Smith & Nephew | Vacuum assisted wound dressing |
JP5613566B2 (en) | 2007-11-21 | 2014-10-22 | スミス アンド ネフュー ピーエルシーSmith & Nephew Public Limited Company | Wound dressing |
US20100203922A1 (en) * | 2009-02-10 | 2010-08-12 | Knecht Thomas A | Time Division Duplex Front End Module |
EP2419157A4 (en) | 2009-04-17 | 2018-01-03 | Kalypto Medical, Inc. | Negative pressure wound therapy device |
US9061095B2 (en) | 2010-04-27 | 2015-06-23 | Smith & Nephew Plc | Wound dressing and method of use |
BR112013030071A2 (en) | 2011-05-24 | 2016-09-20 | Kalypto Medical Inc | device with controller and pump modules to provide negative pressure for wound therapy |
US9058634B2 (en) | 2011-05-24 | 2015-06-16 | Kalypto Medical, Inc. | Method for providing a negative pressure wound therapy pump device |
US9067003B2 (en) | 2011-05-26 | 2015-06-30 | Kalypto Medical, Inc. | Method for providing negative pressure to a negative pressure wound therapy bandage |
US9428799B2 (en) * | 2011-07-25 | 2016-08-30 | Bioinventors & Entrepreneurs Network Llc | Method for determining an allele profile of nucleic acid |
AU2014266943B2 (en) | 2013-05-10 | 2018-03-01 | Smith & Nephew Plc | Fluidic connector for irrigation and aspiration of wounds |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5087559A (en) * | 1988-03-18 | 1992-02-11 | Mount Sinai School Of Medicine Of The City University Of New York | Method of detecting single base substitutions in nucleic acids |
FR2750504A1 (en) * | 1996-06-27 | 1998-01-02 | Appligene Oncor | Analysis of nucleic acids captured on immobilised oligo:nucleotide(s) |
US5795976A (en) * | 1995-08-08 | 1998-08-18 | The Board Of Trustees Of The Leland Stanford Junior University | Detection of nucleic acid heteroduplex molecules by denaturing high-performance liquid chromatography and methods for comparative sequencing |
WO1999007899A1 (en) * | 1997-08-05 | 1999-02-18 | Transgenomic, Inc. | Denaturing multi ion polynucleotide chromatography for detecting mutations |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IS1355B6 (en) | 1984-11-12 | 1989-04-19 | Lister Institute Of Preventive Medicine | Multicolor explores |
US5512439A (en) * | 1988-11-21 | 1996-04-30 | Dynal As | Oligonucleotide-linked magnetic particles and uses thereof |
US6107026A (en) | 1991-07-15 | 2000-08-22 | Lange, Iii; Louis G. | Methods and reagents for RFLP analysis of the human pancreatic cholesterol esterase gene |
JPH07500734A (en) * | 1991-10-31 | 1995-01-26 | ユニヴァーシティ オブ ピッツバーグ | Method for detecting nucleic acid sequences using oligonucleotide probe polymers |
FR2686621B1 (en) * | 1992-01-24 | 1996-03-15 | Appligene Sa | METHOD OF DETECTING MUTATIONS BY ELECTROPHORESIS IN GRADIENT OF DENATURATION OF DOUBLE-STRANDED DNA STABILIZED BY PHOTOPONTAGE. |
US6110709A (en) | 1994-03-18 | 2000-08-29 | The General Hospital Corporation | Cleaved amplified modified polymorphic sequence detection methods |
US5942390A (en) * | 1996-01-12 | 1999-08-24 | Cedars-Sinai Medical Center | Method of diagnosing predisposition for ulcerative colitis in Jewish population by detection of interleukin-1 receptor antagonist polymorphism |
US6153013A (en) | 1996-02-16 | 2000-11-28 | Canon Kabushiki Kaisha | Deposited-film-forming apparatus |
US5842787A (en) | 1997-10-09 | 1998-12-01 | Caliper Technologies Corporation | Microfluidic systems incorporating varied channel dimensions |
US6180536B1 (en) | 1998-06-04 | 2001-01-30 | Cornell Research Foundation, Inc. | Suspended moving channels and channel actuators for microfluidic applications and method for making |
US6107908A (en) * | 1998-08-17 | 2000-08-22 | Santa Cruz; Cathy D. | Blown fuse commutator strip and method of use |
AU6163399A (en) | 1998-09-25 | 2000-04-17 | Massachusetts Institute Of Technology | Methods and products related to genotyping and dna analysis |
US6410231B1 (en) | 1999-02-26 | 2002-06-25 | Incyte Genomics, Inc. | SNP detection |
AU3519900A (en) | 1999-03-19 | 2000-10-09 | Aclara Biosciences, Inc. | Methods for single nucleotide polymorphism detection |
EP1173612B1 (en) | 1999-04-09 | 2004-09-29 | Keygene N.V. | METHOD FOR THE DETECTION AND/OR ANALYSIS, BY MEANS OF PRIMER EXTENSION TECHNIQUES, OF SINGLE NUCLEOTIDE POLYMORPHISMS IN RESTRICTION FRAGMENTS, IN PARTICULAR IN AMPLIFIED RESTRICTION FRAGMENTS GENERATED USING AFLP$m(3) |
EP1173611A4 (en) | 1999-04-12 | 2003-01-15 | Nanogen Inc | Methods for determination of single nucleic acid polymorphisms using a bioelectronic microchip |
JP3888807B2 (en) | 1999-08-06 | 2007-03-07 | 凸版印刷株式会社 | Gene detection method, detection apparatus, and detection chip |
-
2001
- 2001-03-12 US US09/804,589 patent/US6596487B2/en not_active Expired - Fee Related
- 2001-03-12 AU AU2001245650A patent/AU2001245650A1/en not_active Abandoned
- 2001-03-12 WO PCT/US2001/007906 patent/WO2001068919A2/en active Application Filing
-
2003
- 2003-05-23 US US10/444,622 patent/US20030175798A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5087559A (en) * | 1988-03-18 | 1992-02-11 | Mount Sinai School Of Medicine Of The City University Of New York | Method of detecting single base substitutions in nucleic acids |
US5795976A (en) * | 1995-08-08 | 1998-08-18 | The Board Of Trustees Of The Leland Stanford Junior University | Detection of nucleic acid heteroduplex molecules by denaturing high-performance liquid chromatography and methods for comparative sequencing |
FR2750504A1 (en) * | 1996-06-27 | 1998-01-02 | Appligene Oncor | Analysis of nucleic acids captured on immobilised oligo:nucleotide(s) |
WO1999007899A1 (en) * | 1997-08-05 | 1999-02-18 | Transgenomic, Inc. | Denaturing multi ion polynucleotide chromatography for detecting mutations |
Also Published As
Publication number | Publication date |
---|---|
US6596487B2 (en) | 2003-07-22 |
AU2001245650A1 (en) | 2001-09-24 |
US20020042060A1 (en) | 2002-04-11 |
WO2001068919A3 (en) | 2002-12-05 |
US20030175798A1 (en) | 2003-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6596487B2 (en) | Mutation detection using denaturing gradients | |
US5641658A (en) | Method for performing amplification of nucleic acid with two primers bound to a single solid support | |
US6156178A (en) | Increased throughput analysis of small compounds using multiple temporally spaced injections | |
Cheng et al. | Analysis of ligase chain reaction products amplified in a silicon-glass chip using capillary electrophoresis | |
Nordfors et al. | Large‐scale genotyping of single nucleotide polymorphisms by Pyrosequencing™ and validation against the 5′ nuclease (Taqman®) assay | |
WO1995025815A1 (en) | A dna meltometer and methods of use thereof | |
JP3124969B2 (en) | Method and apparatus for separating and detecting mixture components by temperature gradient gel electrophoresis | |
US20040019005A1 (en) | Methods for parallel measurement of genetic variations | |
US20040058349A1 (en) | Methods for identifying nucleotides at defined positions in target nucleic acids | |
US6258534B1 (en) | Pressure-controlled nucleic acid hybridization | |
EP0838527A1 (en) | Method for measuring the concentration of polynucleotides | |
AU2001235856B2 (en) | Method for analysing the length of a nucleic acid molecule | |
US6872530B2 (en) | Method for determining the presence of DNA variants using peptide nucleic acid probes | |
JP2005525797A (en) | Method and apparatus for performing submicroliter reaction using nucleic acid or protein | |
JP2004512850A5 (en) | ||
AU2001235856A1 (en) | Method for analysing the length of a nucleic acid molecule | |
JP3186259B2 (en) | Gene polymorphism analysis method and analyzer using capillary electrophoresis | |
US6533912B2 (en) | Increased throughput analysis of small compounds using multiple temporally spaced injections | |
US6566141B2 (en) | Method of detecting mutation in base sequence of nucleic acid | |
Wang et al. | The method of single-nucleotide variations detection using capillary electrophoresis and molecular beacons | |
WO2002063043A1 (en) | Multitemperature single strand conformation polymorphism (msscp) | |
Curcio | Improved techniques for high-throughput molecular diagnostics | |
van Pelt-Verkuil et al. | Analysis of PCR amplification products | |
US20100291695A1 (en) | Detection of nucleic acid sequence modification | |
ATHANASSIADOU | Competitive Oligopriming |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DE DK DK DM DZ EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DE DK DK DM DZ EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: COMMUNICATION PURSUANT TO RULE 85A(1) EPC, DATE OF NOTIFICATION 12.06.2003,FORM 1217N. |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS (R.69(1)EPC), EPO FORM 2524 OF NOVEMBER 12, 2003. |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |